See more : SPEL Semiconductor Limited (SPELS.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Endexx Corporation (EDXC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Endexx Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Skyline Investments Inc. (SKLN.TA) Income Statement Analysis – Financial Results
- Phreesia, Inc. (0A23.L) Income Statement Analysis – Financial Results
- Citychamp Watch & Jewellery Group Limited (CEBTF) Income Statement Analysis – Financial Results
- Pioneering Technology Corp. (PTE.V) Income Statement Analysis – Financial Results
- GL Events SA (0IX0.L) Income Statement Analysis – Financial Results
Endexx Corporation (EDXC)
About Endexx Corporation
Endexx Corporation engages in the manufacturing and sale of cannabidiol (CBD)-based products for the health and wellness market. It provides CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products, as well as hemp-derived health and beauty care products for supporting the therapeutic relief of pain and inflammation for humans and pets through its e-commerce site cbdunlimited.com, as well as other online and in-store retailers. The company was formerly known as CBD Unlimited, Inc. and changed its name to Endexx Corporation in May 2020. Endexx Corporation is headquartered in Cave Creek, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.91M | 1.28M | 650.52K | 1.97M | 1.50M | 797.55K | 418.39K | 220.76K | 126.26K | 34.64K | 0.00 |
| Cost of Revenue | 5.06M | 774.57K | 994.59K | 606.62K | 823.58K | 449.25K | 212.46K | 166.54K | 115.72K | 732.00 | 0.00 |
| Gross Profit | -1.15M | 503.01K | -344.08K | 1.36M | 674.49K | 348.30K | 205.93K | 54.22K | 10.54K | 33.91K | 0.00 |
| Gross Profit Ratio | -29.39% | 39.37% | -52.89% | 69.22% | 45.02% | 43.67% | 49.22% | 24.56% | 8.35% | 97.89% | 0.00% |
| Research & Development | 5.25K | 27.07K | 10.15K | 15.27K | 20.72K | 43.64K | 8.11K | 18.74K | 57.47K | 115.99K | 2.00K |
| General & Administrative | 0.00 | 3.25M | 3.22M | 3.50M | 3.30M | 1.06M | 449.88K | 763.69K | 879.84K | 533.87K | 234.70K |
| Selling & Marketing | 0.00 | 564.08K | 1.78M | 445.14K | 255.90K | 108.10K | 52.27K | 41.83K | 36.97K | 59.38K | 0.00 |
| SG&A | 4.09M | 3.82M | 5.00M | 3.95M | 3.30M | 1.17M | 502.14K | 805.53K | 916.82K | 593.25K | 234.70K |
| Other Expenses | 0.00 | 20.61K | 20.40K | 15.45K | 25.18K | 65.05K | 2.64K | 2.64K | 67.72K | 35.78K | -599.00 |
| Operating Expenses | 4.09M | 3.87M | 5.03M | 3.98M | 3.35M | 1.22M | 512.90K | 826.92K | 976.72K | 710.32K | 237.07K |
| Cost & Expenses | 9.15M | 4.64M | 6.02M | 4.59M | 4.17M | 1.67M | 725.36K | 993.45K | 1.09M | 710.32K | 237.07K |
| Interest Income | 0.00 | 1.24M | 950.55K | 3.13M | 1.48M | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 | 0.00 |
| Interest Expense | 3.80M | 1.24M | 950.55K | 3.13M | 1.90M | 435.72K | 306.75K | 3.97K | 270.99K | 2.00 | 0.00 |
| Depreciation & Amortization | 9.67K | 20.61K | 20.40K | 15.45K | 17.42K | 10.64K | 2.64K | 2.64K | 2.43K | 1.08K | -374.00 |
| EBITDA | -4.67M | -3.65M | -5.37M | -5.73M | -6.78M | -1.33M | -276.13K | -770.05K | -896.03K | -674.60K | -236.70K |
| EBITDA Ratio | -119.45% | -352.65% | -1,020.65% | -146.48% | -585.00% | -100.28% | -72.74% | -348.83% | -709.65% | -2,616.83% | 0.00% |
| Operating Income | -5.24M | -3.36M | -5.37M | -2.62M | -2.67M | -867.48K | -306.97K | -772.70K | -966.18K | -675.68K | -237.07K |
| Operating Income Ratio | -134.08% | -263.17% | -825.70% | -132.73% | -178.50% | -108.77% | -73.37% | -350.02% | -765.21% | -1,950.57% | 0.00% |
| Total Other Income/Expenses | -3.23M | -1.23M | -1.44M | -5.45M | -3.99M | -1.63M | -361.76K | -3.97K | -84.16K | 267.66K | -599.00 |
| Income Before Tax | -8.47M | -4.13M | -6.81M | -8.06M | -9.66M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
| Income Before Tax Ratio | -216.81% | -323.19% | -1,046.58% | -409.01% | -644.73% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.88% | 0.00% |
| Income Tax Expense | -1.98M | 766.71K | 950.55K | 3.13M | 1.73M | -434.95K | 306.75K | -1.00 | 338.71K | -231.87K | 747.00 |
| Net Income | -6.50M | -4.90M | -7.76M | -11.19M | -11.39M | -1.74M | -668.73K | -776.66K | -1.17M | -408.02K | -237.67K |
| Net Income Ratio | -166.26% | -383.20% | -1,192.70% | -567.92% | -760.28% | -217.94% | -159.83% | -351.82% | -926.20% | -1,177.89% | 0.00% |
| EPS | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.03 | -0.03 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 259.70M | 235.54M | 216.32M | 211.71M | 199.04M |
| Weighted Avg Shares Out (Dil) | 504.71M | 503.98M | 455.05M | 379.17M | 343.49M | 289.10M | 262.47M | 235.54M | 216.32M | 211.71M | 199.04M |
Endexx Corporation Announces Uplisting to OTCQB Venture Market
CAVE CREEK, AZ, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today that it has successfully uplisted from the OTC® Pink Market to the OTCQB®...
No menthol, no problem: flavor bans create opportunities for no-nicotine alternatives
The prohibition of flavored cigarettes, cigars, and vapes in the United States is creating an opportunity for companies producing no-nicotine alternatives, with brands already stepping up to fill empty shelf space. In 2020, the US Food and Drug Administration (FDA)...
Aurora Cannabis tops earnings expectations, Endexx posts 2022 profit and other cannabis sector highlights from this week
A number of cannabis companies posted their latest financial results this week and it was a mixed bag. Endexx announced that it swung to a profit in the 2022 financial year driven by its acquisition of Hyla, while Aurora Cannabis...
Endexx division HYLA secures distribution deal for ‘no nicotine' vape products in the Middle East
Endexx said its HYLA division has entered into an eight-country distribution agreement for its “no nicotine” vape products in the Middle East with Sahara Pacific for Electronic Cigarettes & Accessories Trading Company (Sahara Trading). Sahara Trading will organize and lead the...
Endexx reports 2022 profit and revenue surge fueled by Hyla acquisition
Endexx Corp. announced that it swung to a profit in the 2022 financial year driven by its acquisition of a 51% controlling interest in Hyla US, reduced production costs, and a decrease in inventory impairment.
Endexx reports jump in revenues boosted by the acquisition of Hyla
Endexx Corp. (OTC:EDXC) has reported a jump in revenues for the second quarter and the first half of its current financial year, boosted by the acquisition of vape business Hyla. For its second quarter ending March 31, 2023, Endexx saw consolidated...
Endexx inks $1M plus purchase order for HYLA products in Egypt
Endexx Corp. has announced that its HYLA team has secured a distribution agreement and purchase order contract for the sale of its vape products in Egypt.
Endexx reports 17% increase in 1Q revenues on higher CBD wellness and Skincare sales
ENDEXX Corp. (OTC:EDXC) told investors it continues to grow its CBD wellness and Skincare revenues despite supply chain issues that continue to impact production, packaging and individual ingredient availability. Releasing first-quarter fiscal 2023 results revealing a 17% increase in sales...
Endexx says it is positioned for more growth after doubling 2022 revenue
ENDEXX Corp. (OTC:EDXC) has reported a near doubling in fiscal 2022 revenue and said growth in the year ahead will be supported by a recent restructuring aimed at optimizing its growth potential and expanding its product offerings internationally. The provider...
Endexx to Present at Sequire Virtual Small Cap Conference on December 8th, 2022
Presentation on Thursday, December 8th, 2022 at 1:00 PM ET
Source: https://incomestatements.info
Category: Stock Reports